1. Impact of diabetes mellitus on the risk of Alzheimer’s disease: a mendelian randomization study
- Author
-
Weichao Wang, Jie Zhang, Man Zhang, Chengyuan Zhang, Huanli Liu, Wanlin Li, and Yimeng Fan
- Subjects
Alzheimer’s disease ,Blood pressure ,Diabetes mellitus ,Insulin ,Total cholesterol ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Background The impact of diabetes on the risk of Alzheimer’s disease remains uncertain. This study aimed to explore this issue from multiple perspectives by using the Mendelian randomization (MR) approach. Methods Instrumental variables for predicting six diabetic traits (including insulin and blood glucose), eight metabolic risk factors for diabetes (including total cholesterol and blood pressure), and seven diabetic genes were extracted from their summary data. These data were derived from multiple European cohorts and included 31,684 to 810,865 subjects respectively. The two-sample MR, multivariate MR, and summary-data-based Mendelian randomization (SMR) methods were employed to determine the associations of these traits or genes with the risk of Alzheimer’s disease. Results The two-sample MR showed that elevated fasting insulin and total cholesterol levels were associated with an increased risk of dementia in Alzheimer’s disease (P = 0.022, P = 0.041). Elevated systolic and diastolic blood pressure levels were associated with a decreased risk of dementia in Alzheimer’s disease (P = 0.036, P = 0.025). The multivariate MR reported that adjusting for telomere length (a well-established biomarker of aging) did not change these findings (P
- Published
- 2024
- Full Text
- View/download PDF